Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions
Asthma
Interventions
DRUG

albuterol sulfate inhalation aerosol

Trial Locations (29)

13502

GSK Investigational Site, Utica

13790

GSK Investigational Site, Johnson City

15241

GSK Investigational Site, Pittsburgh

17033

GSK Investigational Site, Hershey

22180

GSK Investigational Site, Vienna

30342

GSK Investigational Site, Atlanta

31406

GSK Investigational Site, Savannah

33765

GSK Investigational Site, Clearwater

35216

GSK Investigational Site, Hoover

43205

GSK Investigational Site, Columbus

45406

GSK Investigational Site, Dayton

45424

GSK Investigational Site, Huber Heights

60115

GSK Investigational Site, DeKalb

63141

GSK Investigational Site, St Louis

64108

GSK Investigational Site, Kansas City

69301

GSK Investigational Site, Alliance

70001

GSK Investigational Site, Metairie

70471

GSK Investigational Site, Mandeville

72401

GSK Investigational Site, Jonesboro

75230

GSK Investigational Site, Dallas

77070

GSK Investigational Site, Houston

80218

GSK Investigational Site, Denver

86426

GSK Investigational Site, Fort Mohave

90723

GSK Investigational Site, Paramount

91801

GSK Investigational Site, Alhambra

92647

GSK Investigational Site, Huntington Beach

02114-3139

GSK Investigational Site, Boston

00917

GSK Investigational Site, Hato Rey

00716

GSK Investigational Site, Ponce

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY